Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/31415
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2023-03-08T06:27:10Z | - |
dc.date.available | 2023-03-08T06:27:10Z | - |
dc.date.issued | 2007 | - |
dc.identifier.citation | Yalçınkaya, U. vd. (2007). "Significance of p53 expression in gastrointestinal stromal tumors". Hepato-Gastoenterology, 54(73), 140-143. | en_US |
dc.identifier.issn | 0172-6390 | - |
dc.identifier.uri | http://hdl.handle.net/11452/31415 | - |
dc.description.abstract | Background/Aims: Gastrointestinal stromal tumors are non-epithelial tumors originating from the gastrointestinal tract walls. They expose a wide spectrum of histological properties from benign to poorly differentiated malignant tumors. Methodology: In this study 41 cases of gastrointestinal stromal tumors were reviewed for p53 expression using immunohistochemical stains. Immunoreactivity properties of the tumors were compared to prognostic factors such as mitotic index, tumor size, tumor site, presence of necrosis, mucosal invasion, proliferative index, telomerase activity, hemorrhage, cellularity, and histological pattern. Results: There was a significant difference in positive immunostaining of three case groups (12.2% in benign, 19.5% in borderline, and 68.3% in malignant group). Statistical analysis revealed a statistically significant positive correlation between p53 immunostaining properties and tumor size (p=0.01), mitotic index (p=0.05), cellularity (p=0.042), and diagnosis (p=0.01). Conclusions: We conclude that p53 expression may be a useful tool in classifying and predicting the prognosis of gastrointestinal stromal tumors as it is well correlated with tumor size, mitotic index, cellularity, and diagnosis according to our study results. | en_US |
dc.language.iso | en | en_US |
dc.publisher | H G E Update Medical Publishing | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Gastrointestinal stromal tumors | en_US |
dc.subject | p53 expression | en_US |
dc.subject | Prognosis | en_US |
dc.subject | Features | en_US |
dc.subject | Gastroenterology & hepatology | en_US |
dc.subject | Surgery | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Middle aged | en_US |
dc.subject.mesh | Gastrointestinal stromal tumors | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Retrospective studies | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mitotic index | en_US |
dc.subject.mesh | Tumor suppressor protein p53 | en_US |
dc.title | Significance of p53 expression in gastrointestinal stromal tumors | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000245252200030 | tr_TR |
dc.identifier.scopus | 2-s2.0-34047156009 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Patoloji Bölümü. | tr_TR |
dc.identifier.startpage | 140 | tr_TR |
dc.identifier.endpage | 143 | tr_TR |
dc.identifier.volume | 54 | tr_TR |
dc.identifier.issue | 73 | tr_TR |
dc.relation.journal | Hepato-Gastroenterology | en_US |
dc.contributor.buuauthor | Yalçınkaya, Ulviye | - |
dc.contributor.buuauthor | Yerci, Ömer | - |
dc.contributor.buuauthor | Koç, Ebru Uzun | - |
dc.contributor.researcherid | AAH-8924-2021 | tr_TR |
dc.identifier.pubmed | 17419248 | tr_TR |
dc.subject.wos | Gastroenterology & hepatology | en_US |
dc.subject.wos | Surgery | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | Pubmed | en_US |
dc.wos.quartile | Q3 (Surgery) | en_US |
dc.wos.quartile | Q4 | en_US |
dc.contributor.scopusid | 6508300295 | tr_TR |
dc.contributor.scopusid | 6603810549 | tr_TR |
dc.contributor.scopusid | 16175576400 | tr_TR |
dc.subject.scopus | Gastrointestinal Stromal Tumors; Imatinib; Sunitinib | en_US |
dc.subject.emtree | Aged | en_US |
dc.subject.emtree | Protein p53 | en_US |
dc.subject.emtree | Adolescent | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Bleeding | en_US |
dc.subject.emtree | Protein expression | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Priority journal | en_US |
dc.subject.emtree | Cancer invasion | en_US |
dc.subject.emtree | Cell proliferation | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Enzyme activity | en_US |
dc.subject.emtree | Mitosis index | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Tumor localization | en_US |
dc.subject.emtree | Gastrointestinal stromal tumor | en_US |
dc.subject.emtree | Immunoreactivity | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Immunohistochemistry | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Mucosa | en_US |
dc.subject.emtree | Prognosis | en_US |
dc.subject.emtree | Review | en_US |
dc.subject.emtree | Tumor necrosis | en_US |
dc.subject.emtree | Tumor volume | en_US |
dc.subject.emtree | Telomerase | en_US |
Appears in Collections: | PubMed Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.